vix.ing · top · new · best · stats · spec

Marine Gross-Goupil

  1. Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 Study
    2020/02/10 by Emmanuel S. Antonarakis, Josep M. Piulats, Marine Gross-Goupil +21 · 1 citation